Reply to the comment of Mathieu et al., "American guidelines for the management of gout as seen by general practitioners"

Julia Goossens (1) , Sylvie Lancrenon (2) , Sabine Lanz (3) , Hang-Korng Ea (4, 1, 5) , Charles Lambert (6) , Pascal Guggenbuhl (7, 8, 9) , Alain Saraux (10) , Catherine Delva (11) , Samy Sahbane (11) , Frédéric Lioté (4, 1, 5)

1 Service de Rhumatologie [CHU Lariboisière]
2 Sylia-Stat [Bourg-La-Reine, France]
3 Laboratoires Mayoly-Spindler [Chatou, France]
4 BIOSCAR (UMR_S_1132 / U1132) - Biologie de l'Os et du Cartilage : Régulations et Ciblages Thérapeutiques
5 USPC - Université Sorbonne Paris Cité
6 Laboratoires Ipsen Pharma [Boulogne-Billancourt, France]
7 Foie, métabolismes et cancer
8 Service de rhumatologie [Rennes] = Rheumatology [Rennes]
9 UR Médecine - Université de Rennes - Faculté de Médecine
10 CHU - BREST - Rhumato - CHRU Brest - Service de Rhumatologie
11 Vivactis Etudes Cliniques [Courbevoie, France]

Domains: Life Sciences [q-bio]; Human health and pathology; Rhumatology and musculoskeletal system

Julia Goossens, Sylvie Lancrenon, Sabine Lanz, Hang-Korng Ea, Charles Lambert, et al.. Reply to the comment of Mathieu et al., "American guidelines for the management of gout as seen by general practitioners". Joint Bone Spine, 2019, 86 (2), pp.279-280. ⟨10.1016/j.jbspin.2018.09.018⟩. ⟨hal-01903475⟩